NasdaqGS - Delayed Quote USD

Kyverna Therapeutics, Inc. (KYTX)

2.6500
+0.1000
+(3.92%)
At close: June 2 at 4:00:02 PM EDT
2.7400
+0.09
+(3.40%)
Pre-Market: 7:43:02 AM EDT
All numbers in thousands
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
304,645
75,195
66,924
85,488
Total Liabilities Net Minority Interest
38,058
206,592
140,921
131,742
Total Equity Gross Minority Interest
266,587
-131,397
-73,997
-46,254
Total Capitalization
266,587
-131,397
-73,997
-46,254
Common Stock Equity
266,587
-131,397
-73,997
-46,254
Capital Lease Obligations
8,242
9,079
10,564
5,555
Net Tangible Assets
266,587
-131,397
-73,997
-46,254
Working Capital
256,845
40,805
41,297
61,159
Invested Capital
266,587
-131,397
-73,997
-46,254
Tangible Book Value
266,587
-131,397
-73,997
-46,254
Total Debt
8,242
9,079
10,564
5,555
Share Issued
43,214.9180
43,115.2440
40,822.5250
40,822.5250
Ordinary Shares Number
43,214.9180
43,115.2440
40,822.5250
40,822.5250
12/31/2021 - 2/9/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers